Pentostatin plus cyclophosphamide and bexarotene is an effective and safe combination in patients with mycosis fungoides/Sezary syndrome. [electronic resource]
Producer: 20130822Description: 130-2 p. digitalISSN:- 1365-2141
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bexarotene
- Cyclophosphamide -- administration & dosage
- Humans
- Mycosis Fungoides -- drug therapy
- Pentostatin -- administration & dosage
- Sezary Syndrome -- drug therapy
- Skin Neoplasms -- drug therapy
- Tetrahydronaphthalenes -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.